1. Home
  2. VIRT vs BLCO Comparison

VIRT vs BLCO Comparison

Compare VIRT & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIRT
  • BLCO
  • Stock Information
  • Founded
  • VIRT 2008
  • BLCO 1853
  • Country
  • VIRT United States
  • BLCO Canada
  • Employees
  • VIRT N/A
  • BLCO N/A
  • Industry
  • VIRT Investment Bankers/Brokers/Service
  • BLCO Ophthalmic Goods
  • Sector
  • VIRT Finance
  • BLCO Health Care
  • Exchange
  • VIRT Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • VIRT 3.3B
  • BLCO 4.0B
  • IPO Year
  • VIRT 2015
  • BLCO 2022
  • Fundamental
  • Price
  • VIRT $40.50
  • BLCO $11.45
  • Analyst Decision
  • VIRT Hold
  • BLCO Hold
  • Analyst Count
  • VIRT 8
  • BLCO 12
  • Target Price
  • VIRT $37.25
  • BLCO $15.59
  • AVG Volume (30 Days)
  • VIRT 855.5K
  • BLCO 779.5K
  • Earning Date
  • VIRT 07-17-2025
  • BLCO 04-30-2025
  • Dividend Yield
  • VIRT 2.36%
  • BLCO N/A
  • EPS Growth
  • VIRT 142.03
  • BLCO N/A
  • EPS
  • VIRT 3.46
  • BLCO N/A
  • Revenue
  • VIRT $2,401,575,000.00
  • BLCO $4,829,000,000.00
  • Revenue This Year
  • VIRT N/A
  • BLCO $6.97
  • Revenue Next Year
  • VIRT N/A
  • BLCO $5.44
  • P/E Ratio
  • VIRT $11.76
  • BLCO N/A
  • Revenue Growth
  • VIRT 43.16
  • BLCO 11.94
  • 52 Week Low
  • VIRT $21.59
  • BLCO $10.45
  • 52 Week High
  • VIRT $44.58
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • VIRT 47.42
  • BLCO 42.87
  • Support Level
  • VIRT $39.47
  • BLCO $10.99
  • Resistance Level
  • VIRT $41.61
  • BLCO $12.05
  • Average True Range (ATR)
  • VIRT 1.01
  • BLCO 0.38
  • MACD
  • VIRT -0.31
  • BLCO 0.06
  • Stochastic Oscillator
  • VIRT 31.84
  • BLCO 32.55

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages cutting edge technology to deliver liquidity to the global markets and innovative, transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: